o-High-dose sodium thiopental is frequently used in neuroanesthesia. The authors performed a study to compare a shorter-acting barbiturate, methohexital, to sodium thiopental in producing high-dose barbiturate anesthesia. In two groups of five mongrel dogs each, regional cerebral blood flow (CBF) was determined using the radioactive-microsphere technique, and cardiovascular parameters were measured before, during, and 1 hour after a 1 89 period of deep barbiturate anesthesia with either sodium thiopental or methohexital. Doses of the barbiturates were adjusted to produce electroencephalogram burst suppression of greater than 30 seconds.
H
IGH-DOSE barbiturate anesthesia has been used during neurosurgical procedures to improve brain relaxation and for its possible protective effect during ischemia due to temporary or permanent vessel occlusion. 9'~4 One of the major disadvantages of the most widely used agent, sodium thiopental, is the long period of time required for patients to fully awaken. 6-8'23 This study was performed to compare a shorter-acting barbiturate, methohexital, to sodium thiopental in producing high-dose barbiturate anesthesia.
Materials and Methods
Two groups of five mongrel dogs, weighing approximately 15 kg each, were anesthetized with 1.5 mg/kg morphine and 70% nitrous oxide with 30% oxygen. Muscular paralysis was achieved with intravenous pancuronium, 0.2 mg/kg, supplemented as necessary. A Harvard pump respirator* was used to hyperventilate the dogs, and COz was added to the inspired gas mixture to maintain anterial pCO2 at 40 tO1T. Core temperature was measured from the thermistor in the Swan-Ganz cathetert and maintained at 37"C with a heating blanket.
Systemic arterial pressure was monitored from a catheter introduced into the aorta through the brachial artery. Sagittal sinus pressure was measured from a catheter placed in the anterior sagittal sinus and directed caudally into the posterior third of the sinus. Pulmonary artery wedge pressure, central venous pressure, and cardiac output (using the thermodilution technique) were measured from a Swan-Ganz catheter inserted through the femoral vein. Left ventricle end diastolic pressure was measured using a pigtail catheter inserted retrogradely through the femoral artery and positioned manometrically. The heart rate was derived from the electrocardiogram. These physiological pa-rameters were recorded continuously on a HewlettPackard 8800 eight-channel strip chart recorder. End-tidal CO2 was measured continuously with a Hewlett-Packard 47210A capnometer., The electroencephalogram (EEG) was monitored from four needle electrodes placed in the scalp and recorded on a Grass Model 8-10C electroencephalograph.w Blood flow to the brain and spinal cord, fight and left ventricles of the heart, liver, kidney, stomach, jejunum, and temporalis and paraspinous muscles was measured using the radioactive-microsphere technique. Regions of the central nervous system studied were the cortical gray matter, samples including mixed white and gray matter from the right and left hemispheres, the corpus callosum, the right and left caudate nuclei, the brain stem, the cerebellum, and the cervical and thoracic spinal cord. In each animal, six determinations of blood flow were made using 15 _+ 5-u carbonized spheres labeled with gadolinium-153, cerium-14 l, tin-I 13, strontium-85, niobium-95, and scandium-46. The microspheres were injected into the left ventricle through the pigtail catheter. Femoral and brachial artery reference samples were withdrawn at a rate of 1.03 ml/min for 30 seconds before and for 3 89 minutes after injection of the microspheres. The amount of each isotope in the blood and tissue samples was determined by counting in a Packard auto-gamma scintillation spectrometer. II Immediately prior to each blood flow determination, blood was drawn for measurement of arterial blood gases, barbiturate levels, hematocrit, and oxygen content of arterial and cerebral venous (sagittal sinus) blood. Cardiac index was obtained by dividing the cardiac output by the animal's weight. Cardiac work was calculated by multiplying the difference between the mean arterial blood pressure (MABP) and the left ventricle end-diastolic pressure by the stroke volume multiplied by 1.33 x 10 -3. Cerebral metabolic rate of oxygen (CMRO2) was estimated by multiplying the difference between the arterial and sagittal sinus oxygen content by the mean cerebral hemisphere blood flow. Cerebral perfusion pressure was calculated as the difference between the MABP and sagittal sinus pressure. Cerebral vascular resistance (CVR) was calculated by dividing the cerebral perfusion pressure by the total mean cerebral blood flow (CBF). Peripheral vascular resistance was calculated by dividing the difference between the mean arterial and central venous pressures by the cardiac index.
After completion of the surgical procedures, the animals were allowed to stabilize for approximately 1 hour, :~ 8800 eight-channel strip chart recorder and 47210A capnometer manufactured by Hewlett-Packard Corp., 16399 West Bernardo Drive, San Diego, California.
w Grass Model 8-10C electroencephalograph manufactured by Grass Instrument Co., 101 Old Colony Avenue, Quincy, Massachusetts.
[I Auto-gamma scintillation spectrometer manufactured by Packard Instrument Co., Downers Grove, Illinois. after which two blood flow measurements were made 5 minutes apart to obtain control values. Cardiovascular parameters were recorded with each injection of microspheres. One gram of sodium thiopental or methohexital was dissolved in 40 cc of sterile water and the agent infused into the femoral vein via a syringe infusion pump. The barbiturate infusion rate was adjusted to produce EEG burst suppression of greater than 30 seconds. An average time of 27 minutes was required to produce a stable 30-second burst-suppression pattern. This degree of burst suppression was maintained for 30 minutes, and two blood flow measurements were made approximately 20 minutes apart. The barbiturate infusion was discontinued, 1 hour was allowed to elapse, and all measurements were repeated twice, approximately 15 minutes apart.
Statistical analysis of the data where necessary was performed using the pooled t-test. Blood flow values are expressed in ml/100 gm/min + standard error of the mean.
Results
The results are discussed in terms of three periods: control levels (before barbiturate infusion), burst suppression, and recovery. The value of each parameter in each of these three periods was obtained by averaging the two determinations within that period.
There was no statistical difference in the degree of burst suppression or the total duration that the barbiturate infusion was maintained between the two groups ( Table 1 ). The average dose of sodium thiopental was 0.9 + 0.1 mg/kg/min and of methohexital was 0.4 + 0.1 mg/kg/min. The barbiturate level at the end of the burst-suppression period was 12 _+ 2 ~g/ml in the methohexital group and 28 + 5 ug/ml in the sodium thiopental group. At the end of the recovery period the methohexital level was 3 + 1 ug/ml and the sodium thiopental level was 21 + 9 ug/ml.
There were no important differences in arterial blood gases, temperature, or hematocrit between the animals that received sodium thiopental and those that received methohexital ( Table 2) .
Barbiturate Infusion Period
The reduction in cardiac index produced by sodium thiopental infusion (57%) and methohexital infusion (54%) was equivalent. However, methohexital produced a greater reduction in MABP than did sodium thiopental (58% versus 40%). This difference was due to a reduction of 21% in peripheral vascular resistance in the methohexital group versus an increase of 24% in the thiopental group (Table 3 , Fig. 1 ). Infusion of either barbiturate resulted in a reduction in systemic organ flow of a similar proportion for both agents. The reductions in the methohexital group and the sodium thiopental group, respectively, were as follows: left ventricle 60% and 50%, fight ventricle 55% and 50%, kidney 58% and 36%, liver 81% and 48%, stomach 81% and 80%, jejunum 38% and 42%, paraspinous muscle 50% and 17%, cervical spinal cord 30% and 20%, thoracic spinal cord 20% and 33% and temporalis muscle 0% and an increase of 50% (Table 4) . * MABP = mean arterial blood pressure; CI = cardiac index; CVP = central venous pressure; LVEDP = left ventricle end-diastolic pressure; SV = stroke volume (cardiac output/heart rate). Statistical difference from control: "~ = p _< 0.05; ~ = p -< 0.01; w = p _< 0.001. None of these differences between methohexital and sodium thiopental was statistically significant. Administration of barbiturates resulted in a 36% reduction in CMROz in the sodium thiopental group and a reduction of 41% in the methohexital group. These differences were not statistically significant. Although there was no statistically significant difference in the reduction in total CBF between the two groups, methohexital infusion resulted in a 47% decrease, while sodium thiopental produced a 57% reduction. There was a markedly different change in CVR between the two groups. In the methohexital group CVR decreased 24%, while in the sodium thiopental group CVR increased 37% (Fig. 2) . The reductions in regional CBF resulting from methohexital and sodium thiopental, respectively, were as follows: caudate nucleus 63% and 62%, corpus callosum 35% and 42%, brain stem 30% and 46%, and cerebellum 32% and 44% (Table 5 , Fig. 3 ).
Recovery Period
With the exception of the greater reduction in MABP in the methohexital group, the cerebral and cardiovas- cular effects of both drugs were similar; however, there was a m u c h more complete recovery at the end of the 1-hour recovery period in the methohexital group. In both groups, EEG activity was continuous within 10 minutes of discontinuing the barbiturate infusion.
FIG. 1. Peripheral vascular resistance during barbiturate infusion increases with sodium thiopental (closed circles) while it decreases with methohexital (open circles). Asterisks
At the end of the 1-hour recovery period, M A B P had returned to 88% of control in the methohexital group, whereas it was 110% of control in the sodium thiopental group. However, cardiac index following methohexital infusion had recovered to 85% of control c o m p a r e d to recovery to only 57% o f control in the sodium thiopental group. Peripheral vascular resistance was 23% above control following methohexital infusion and 80% above control following sodium thiopental administration. The recovery values for CMRO2 had returned to within 20% of control levels in the methohexital group but remained 32% below control in the sodium thiopental group. The pattern of recovery o f total CBF was similar to that of CMRO2: the methohexital group returned to 80% of the control value, while the sodium thiopental group remained 54% below control levels. The changes in regional CBF were proportionally similar to the total CBF. Recovery of systemic organ blood flow was also more rapid in the methohexital group.
Discussion
High-dose barbiturate anesthesia is being used with increasing frequency in neurosurgical patients, particularly those undergoing neurovascular procedures such as carotid endarterectomy, arteriovenous malformation resection, or aneurysmorrhaphy. The principal rationale for use of this modality is that barbiturates decrease cerebral metabolism and thus m a y afford some degree of protection from infarction during periods when the cerebral circulation is c o m p r o m i s e d below the ischemic threshold. ~s'~6'2~'14 Barbiturate administration also reduces cerebral blood volume and hence brain bulk, and may facilitate manipulations during craniotomy.~l'~3
The major advantage of sodium thiopental is that it is a c o m m o n l y used drug with which most anesthesiologists are familiar, and its effects on the cerebral circulation have been well documented. ~-3' 18'9 Major disadvantages are myocardial depression and cardiac arrhythmias, particularly when high doses are administered rapidly, and prolonged awakening time, with significant barbiturate "hangover." This is particularly a problem after lengthy procedures, when high doses of sodium thiopental make neurological evaluation difficult for several hours postoperatively2 ' 6' 8 ' 21 Sodium thiopental acts rapidly but, being a thiobarbiturate, is not truly an ultrashort-acting preparation. After administration, sodium thiopental is initially taken up and stored in body fat and then released slowly and metabolized in the liver. Consequently, after infusion of large amounts of the drug, serum levels may be elevated for prolonged periods of time. 5' 8' 17 Methohexital (Brevital) is an ultrashort-acting oxybarbitone. In contrast to the thiobarbiturates it is rapidly metabolized by microsomal enzymes in the liver. It has very low fat solubility and produces little hangover. 5-8'2~ Following its introduction, methohexital was used for the induction of general anesthesia. The drug's popularity declined due to its tendency to produce prolonged periods of apnea, hiccups, muscle twitching, and shivering. 6' 7 It was shown clinically, however, to be two to three times more potent than sodium thiopental and much more rapidly metabolized than thiobarbiturates. 4, 6 This high potency and rapid metabolism suggest that methohexital could be a useful agent for barbiturate anesthesia in neurosurgical patients. The purpose of this investigation was to compare the cerebral and systemic vascular effects of sodium thiopental and methohexital.
In this study the level of anesthesia was regulated by the EEG changes, with the desired level being burst suppression for an average period of 30 to 60 seconds. In a previous study in dogs treated with sodium pentobarbital we determined that this degree of burst suppression resulted in nearly maximum reduction in CMRO2 with minimum cardiovascular depression. ~~ The EEG changes in the sodium thiopental and methohexital groups were essentially the same during the period of drug infusion, but the serum level of sodium thiopental was nearly twice that of methohexital at the end of the infusion period. This coincides with other reports in which methohexital was found to be twice as potent as sodium thiopental. 4,6 Furthermore, the greater reduction in the methohexital level at the end of the recovery period confirmed that methohexital is much more rapidly metabolized than sodium thiopental.
The cardiovascular effects during the infusion period were different with the two agents. While cardiac index and stroke volume were reduced by the same degree in both groups, MABP was depressed more severely after administration of methohexital. This difference was related to the fact that peripheral vascular resistance decreased in the methohexital group in comparison to the increase noted in the sodium thiopental group. Sodium thiopental has previously been shown to result in mild peripheral vasoconstriction. 11 At the completion of the recovery period there was a proportionally similar return of MABP toward control levels in both groups. However, there was a much greater improvement in cardiac index and stroke volume in the methohexital group than in the sodium thiopental groups. Likewise, there was a more complete return toward control values of CMROz, blood flow to the brain, and other viscera in the methohexital group.
There was little difference between blood flows in the viscera following administration of methohexital or sodium thiopental. In contrast, however, CBF decreased slightly more in the thiopental group, despite an equivalent reduction in CMRO2 by both agents. Sodium thiopental appears to increase resistance in cerebral as well as systemic vessels more than does methohexital. These changes in CVR suggest that sodium thiopental may have different primary vasoactive properties than does methohexital. In certain circumstances, such as aneurysm or arteriovenous malformation surgery, the lower arterial pressure caused by administration of methohexital may be advantageous; however, in other circumstances, such as carotid endarterectomy or extracranial-to-intracranial artery bypass surgery, this may prove to be a disadvantage. The more complete recovery following administration of methohexital would be an advantage in most circumstances where high-dose barbiturate anesthesia is required.
Postoperative seizures have been noted in some patients undergoing prolonged procedures using high-dose methohexital anesthesia. Presumably, this is related to acute habituation and withdrawal of the drug. 6-8 '23 Thus, methohexital would seem to be inappropriate for procedures requiring long periods of anesthesia, such as arteriovenous malformation resection. However, methohexital may be advantageous for procedures requiring a relatively brief period of protection, such as carotid endarterectomy or extracranial-to-intracranial artery bypass which generally require less than 1 hour of vascular occlusion.
Summary
Sodium thiopental and methohexital infused in sufficient doses to produce an equivalent degree of EEG burst suppression result in a similar reduction in CMROz, and hence probably offer similar protective effects in ischemic situations. In these doses, methohexital and sodium thiopental cause a similar degree of myocardial depression. However, the changes in cerebral and peripheral vascular resistance and MABP suggest that sodium thiopental causes more vasoconstriction than methohexital. The cerebral metabolic and systemic vascular changes were reversed more rapidly after discontinuation of the methohexital infusion than they were after discontinuation of the sodium thiopental infusion.
